State v. Hanif

743 S.E.2d 690, 228 N.C. App. 207, 2013 WL 3305326, 2013 N.C. App. LEXIS 723
CourtCourt of Appeals of North Carolina
DecidedJuly 2, 2013
DocketNo. COA12-1108
StatusPublished
Cited by3 cases

This text of 743 S.E.2d 690 (State v. Hanif) is published on Counsel Stack Legal Research, covering Court of Appeals of North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Hanif, 743 S.E.2d 690, 228 N.C. App. 207, 2013 WL 3305326, 2013 N.C. App. LEXIS 723 (N.C. Ct. App. 2013).

Opinion

BRYANT, Judge.

Where we are unable to discern any meaningful distinction between State v. Ward, 364 N.C. 133, 694 S.E.2d 738 (2010), and the instant case, we are compelled to grant defendant a new trial.

On 26 September 2011, defendant was indicted on charges of selling and delivering a counterfeit controlled substance, namely tramadol hydrochloride, which defendant represented to be Vicodin, a Schedule III controlled substance.1 Each of the charges stemmed from events, which occurred on 3 August 2011. Detectives with the Winston-Salem Police Department, assigned to the Special Investigations Division Vice/ Narcotics Unit were working undercover when they were approached by defendant who asked one of the undercover detectives if he wanted to buy some Vicodin. A negotiation ensued, and defendant agreed to sell the detective two pills for four dollars. The detective later testified that defendant pulled from his pants pocket a prescription pill bottle, poured out two pills, and handed them to the detective. Incident to his arrest, defendant was searched and along with two prescription medication bottles - one containing defendant’s personal prescription for tramadol hydrochloride - the officers discovered a clear plastic baggie containing a rock-like substance later determined to be Epsom salt.

Defendant filed a motion in limine to exclude the Epsom salt as well as statements he made before a magistrate, arguing that the baggie of Epsom salt and the statements were irrelevant to the charges and inadmissible at trial. Trial commenced during the 26 March 2012 Criminal Session of Forsyth County Superior Court, the Honorable Ronald E. Spivey, Judge presiding. Prior to impaneling the jury, the trial court held [209]*209a hearing concerning defendant’s motion in limine. At the conclusion of the hearing, the trial court orally announced its ruling denying defendant’s motion to exclude evidence regarding the Epsom salt; suppressing statements made regarding a law enforcement officer who died in an unrelated event; and admitting statements made by defendant to the officers and magistrate during his arrest.

Following the close of the evidence, the jury returned guilty verdicts on the charges of selling or delivering a counterfeit controlled substance and possession of a counterfeit controlled substance with intent to sell or deliver. The trial court entered judgment in accordance with the jury verdicts and sentenced defendant to consecutive active terms of nine to eleven months for each offense. Defendant appeals.

I

Defendant argues that the trial court committed plain error by admitting evidence identifying a particular substance as tramadol hydrochloride based solely upon a visual inspection.2 We agree.

“ [P]lain error review in North Carolina is normally limited to instructional and evidentiary error.” State v. Lawrence, 365 N.C. 506, 516, 723 S.E.2d 326, 333 (2012) (citation omitted).

[T]he plain error rule ... is always to be applied cautiously and only in the exceptional case where, after reviewing the entire record, it can be said the claimed error is a “fundamental error, something so basic, so prejudicial, so lacking in its elements that justice cannot have been done,” or “where [the error] is grave error which amounts to a denial of a fundamental right of the accused,” or the error has “resulted in a miscarriage of justice or in the denial to appellant of a fair trial’ ” or where the error is such as to “seriously affect the fairness, integrity or public reputation of judicial proceedings” or where it can be fairly said “the instructional mistake had a probable impact on the jury’s finding that the defendant was guilty.”

Id. at 516-17, 723 S.E.2d 333 (original emphasis).

[210]*210North Carolina General Statutes, section 90-95(a)(2) states that it is unlawful “[t]o create, sell or deliver, or possess with intent to sell or deliver, a counterfeit controlled substance.” N.C. Gen. Stat. § 90-95(a) (2) (2011). A conviction under this statute requires the State to prove “(1) that defendant possessed a counterfeit controlled substance, and (2) that defendant intended to sell or deliver the controlled substance.” State v. Williams, 164 N.C. App. 638, 644, 596 S.E.2d 313, 317 (2004) (citations and quotations omitted).

Defendant was indicted and tried on charges of selling and delivering a counterfeit controlled substance and possession of a counterfeit controlled substance with intent to sell and deliver. As to both charges, defendant challenges the admission of evidence that the seized pills were counterfeit. Defendant cites State v. Ward, 364 N.C. 133, 694 S.E.2d 738 (2010), in support of his contention that the evidence was impermissibly admitted.

In Ward, the trial court admitted evidence identifying an alleged controlled substance as a controlled substance despite the defendant’s objection. Id. at 138, 694 S.E.2d at 741. Our Supreme Court held that “the trial court abused its discretion by permitting the State’s expert witness to identify certain pills when the expert’s methodology consisted solely of a visual inspection process.” Id. at 134, 694 S.E.2d at 739. The Court reasoned that expert testimony concerning whether a substance introduced at trial meets the technical, scientific definition of a controlled substance requires a chemical analysis. Id. Moreover, the Court explained that “a scientific, chemical analysis must be employed to properly differentiate between the real [controlled substance] and the counterfeit.” Id. at 143, 694 S.E.2d at 745.

Here, State’s witness Mr. Brian King, a forensic chemist with the North Carolina State Crime Lab, testified that after a visual inspection, he identified the pills as tramadol hydrochloride, a prescription medication. On direct examination, Mr. King testified as follows:

Q. Okay. I’m going to hand you what’s marked as State’s 3 and 4. Have you seen these items before?
A. Yes. I have.
Q. Okay. Let’s start with the pills.
[211]*211Q. How did you process those when they came to your lab?
A. When I first removed them from the envelope, I noticed that they were tablets. And my first - since it was in a clear plastic bag, I was able to read the markings on the tablet. And the first thing I went to was my online database.
Q. Okay. How many times do you use that database?
A. For every tablet - every pharmaceutical tablet case I’ve used.
Q. Okay. And what did - what did that investigation yield?
A. The tablet markings - I’ll refer to my worksheet - tablet markings through our Micromedex online database resulted in tramadol hydrochloride.
Q. Okay. Now, have you ever encountered tablets of tramadol hydrochloride before as part of your job?
A. Yes I have.
Q.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Kelly
Court of Appeals of North Carolina, 2025
State v. Thomas
Court of Appeals of North Carolina, 2019
State v. Carter
803 S.E.2d 464 (Court of Appeals of North Carolina, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
743 S.E.2d 690, 228 N.C. App. 207, 2013 WL 3305326, 2013 N.C. App. LEXIS 723, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-hanif-ncctapp-2013.